GlassScriptPhysician profile
Isela Vasquez
NPI 1194929513
$80,827.66
in general payments reported to CMS, 2019-2025
11 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $17K · 2021: $10K · 2022: $14K · 2023: $9,735 · 2024: $5,757 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $2,393 · Travel and Lodging: $2,264 · Gift: $10.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $2,392.99 |
| Travel and Lodging | $2,264.09 |
| Gift | $10.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $75,924.68 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $2,209.21 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Kerecis Limited | $1,280.69 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $997.78 | 2021-2022 | |
| Becton, Dickinson and Company | $130.94 | 2019 | |
| Acell, INC. | $124.09 | 2019 | |
| Conmed Corporation | $78.10 | 2022 | |
| Allergan, INC. | $25.33 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.50 | 2022 | |
| Integra Lifesciences Corporation | $19.16 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $15.18 | 2023 | Alloderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isela Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.